NVO stock declines after a recent obesity study setback and intense competition from market rivals but offers long-term ...

Novo Nordisk has an opportunity to expand indications on its weight loss drugs. Check out on what could be next for NVO stock ...

Authorized generics are the exact copies of branded drugs, sold by another company with the branded drug manufacturer’s ...

The study met its main goal, but those watching closely had hoped for an average result of at least 25% weight loss.

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

Shares of Novo Nordisk (CSE: NOVOb) continued their upward momentum on Tuesday, rising over 5%, following gains on Monday.

The investigational therapy works to impede the expression of genes that cause the body to store fat as a potential treatment ...

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...

Lilly and Novo still dominate the market for weight-loss and diabetes drugs, but the race is heating up in more ways than one ...

The task ahead of Vertex now is to migrate patients already on Trikafta to the new drug. That is supported by data from the ...

Weight loss with Ozempic or Wegovy can come with nausea, but avoiding certain foods and drinks can help patients manage the ...

Biocon and Zentiva receive EU approval for Liraglutide, a complex formulation for diabetes and weight management.